Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2012
11/29/2012WO2012106670A8 Expandable liquid volume in an led bulb
11/29/2012WO2012102937A3 Benz imidazole compounds that expand hematopoietic stem cells
11/29/2012WO2011119610A3 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
11/29/2012US20120302729 Anticancer anti-mortalin peptide antibody
11/29/2012US20120302646 Use of Cannabidiol in the Treatment of Hepatitis
11/29/2012US20120302633 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302627 Method of using adenoviral vectors to induce an immune response
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302606 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120302518 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof
11/29/2012US20120302505 Cyclodextrin-based polymers for therapeutic delivery
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301959 Cryoconserved Mature Dendritic Cells
11/29/2012US20120301548 Oral complex composition comprising pseudoephedrine and levocetirizine
11/29/2012US20120301510 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/29/2012US20120301505 Immunostimulating Agent and Method for Production Thereof
11/29/2012US20120301504 Influenza Virus Recombinant Proteins
11/29/2012US20120301501 Method for selecting and producing vaccine components and vaccines based thereon
11/29/2012US20120301500 Anti-sepsis conjugate vaccine
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301498 Controlled release of immunosuppressants from synthetic nanocarriers
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301492 Compositions and methods for wt1 specific immunotherapy
11/29/2012US20120301486 Compositions and methods for inhibition of the jak pathway
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301466 Chemically programmable immunity
11/29/2012US20120301465 Compositions and methods to immunize against hepatitis c virus
11/29/2012US20120301462 Compounds
11/29/2012US20120301450 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
11/29/2012US20120301435 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/29/2012US20120301430 Thiophene analogues for the treatment or prevention of flavivirus infections
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2837346A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012CA2837199A1 Inhibitors of lrrk2 kinase activity
11/29/2012CA2837184A1 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
11/29/2012CA2836926A1 Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha
11/29/2012CA2834442A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2834440A1 Immunostimulatory oligodeoxynucleotides
11/29/2012CA2833203A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527344A1 Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2526938A2 Histidine decarboxylase inhibitor sole or combined with a leukotriene receptor antagonist, an anti-H1 and/or an anti-H2 to treat COPD or gastrointestinal disorders.
11/28/2012EP2526116A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen
11/28/2012EP2525819A2 Immunotherapy compositions and methods of treatment
11/28/2012EP2525818A2 Immunogenic influenza composition
11/28/2012EP2525811A1 Nutritional formulas containing synbiotics
11/28/2012CN202552133U Health-care bellyband
11/28/2012CN102803248A Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
11/28/2012CN102803238A Oxadiazole derivatives
11/28/2012CN102803237A Oxazole and thiazole derivatives as alx receptor agonists
11/28/2012CN102803234A Antagonism of human formyl peptide receptor for treatment of disease
11/28/2012CN102802667A Method for treating immune disorders
11/28/2012CN102802664A Immunogenic compositions
11/28/2012CN102802648A Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
11/28/2012CN102802641A Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
11/28/2012CN102796743A Improved IL-15 and IL-15R-alpha for expression in mammalian cells
11/28/2012CN102796171A Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796170A Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796169A Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796086A Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof
11/28/2012CN102793919A Pharmaceutical composition and method for producing the same
11/28/2012CN102793846A Production method of chitosan oligosaccharide instant Chinese medicament
11/28/2012CN102793770A Traditional Chinese medicine for treating allergic rhinitis
11/28/2012CN102793766A Preparation method of apostichopus japonicus slow-release type compound immunopotentiator
11/28/2012CN102793753A Health care conditioning oil
11/28/2012CN102793729A Triptolide and chinese brake herb general flavone combined medicinal composition and preparation and application thereof
11/28/2012CN102793728A High-frequency oscillation wall-broken ganoderma lucidum spore powder
11/28/2012CN102793712A Application of chrysin in preparation of medicaments for treating autoimmune and inflammatory diseases
11/28/2012CN102793693A Applications of vorinostat in aspect of drugs for treating autoimmune diseases and inflammatory diseases
11/28/2012CN102793692A Compounds for inflammation and immune-related uses
11/28/2012CN102793690A Application of juglone to preparation of medicament for treating autoimmune and inflammatory diseases
11/28/2012CN102793674A Triptolide solid lipid nanoparticle as well as preparation method and application thereof
11/28/2012CN102793665A Flexible nanoliposomes with procyanidine and preparation method for flexible nanoliposomes
11/28/2012CN102793658A Matrix-type preparation containing mycophenolic acid or mycophenolic acid salt and coated tablet thereof
11/28/2012CN102793436A Pillow
11/28/2012CN102792947A Cryopreservation liquid and injection of mesenchymal stem cells
11/28/2012CN102319400B Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 1172